Recombinant human alkaline phosphatase

Star0

DB17672InvestigationalProtein Based Therapies

Recombinant human alkaline phosphatase: Overview.

Mechanism: Pharmacologically active on Adenosine triphosphate (ATP)
Curator reviewed
Also known as: Human recombinant alkaline phosphatase · Human recombinant AP · Ilofotase alfa · recAP

Resolves to

Compound

UNII9N4Y2R43OM

What you can answer from here — as of July 10, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of Recombinant human alkaline phosphatase, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account